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A B S T R A C T
Background: Impaired response inhibition is one of the most consistent findings in attention deficit hyperactivity
disorder (ADHD). However, the underlying brain mechanisms are not clear. This study aimed to underpin
atypical inhibition-related brain activation and connectivity patterns in ADHD using a novel Go/No-go task
design, and to determine its association with clinical symptoms of the disorder.
Methods: Forty-eight adults with ADHD performed a Go/No-go task in which target frequency was manipulated
during functional MRI. Specific inhibition-related brain activation was correlated with ADHD symptom severity,
to assess the relationship of individual differences in engagement of inhibition-related brain circuits with the
magnitude of every-day functioning impairments. Finally, generalized psychophysical interaction analyses were
carried out to examine whether not only engagement but also functional connectivity between regions im-
plicated in response inhibition is related to symptom severity.
Results: We found no evidence for the expected parietal modulation by increased demand for inhibition at the
group-level results. However, this lack of modulation was mediated by individual differences in ADHD symptom
severity – increased engagement of the intraparietal sulcus (IPS) in inhibition-demanding events was evident in
individuals with less severe symptoms but dissipated with increase in symptomatology. Similarly, functional
connectivity between the IPS and the right inferior frontal gyrus (rIFG) was elevated under high inhibitory
demand conditions, but this effect diminished with increased symptom severity.
Conclusions: The results highlight the importance of IPS engagement in response inhibition and suggest that IPS
modulation may be driven by top-down control from the IFG. Moreover, the current findings force the point of
treating ADHD as a continuum whereby brain correlates are scaled with severity of the disorder, and point to the
potential use of individual differences in the modulation of IPS activation and connectivity as a neuromarker of
ADHD.
1. Introduction
Attention deficit hyperactivity disorder (ADHD) is defined by be-
havioral symptoms of inattention, hyperactivity and impulsivity; trou-
bling approximately 5% of children and 2.5% of adults
(American Psychiatric Association, 2013; Polanczyk et al., 2007;
Simon et al., 2009). While ADHD tends to manifest in a range of
symptoms, it is thought that deficient response inhibition - reduced
ability to suppress inadequate but prepotent response tendencies - is
one of the central dysfunctions characterizing the disorder
(Barkley, 1997; Nigg, 2001; Wright et al., 2014). The most common
paradigms used to study response inhibition are Go/No-go and Stop-
Signal tasks (Polner et al., 2015) where poor inhibitory control is be-
haviorally reflected in high rate of commission errors (i.e. false alarms)
in Go/No-go tasks and in long stop-signal reaction time (SSRT) in Stop-
Signal tasks (i.e. it takes longer to cancel an ongoing response). It has
been consistently demonstrated that response inhibition, as assessed
with these tasks, is deficient both in children and in adults with ADHD
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(Hervey et al., 2004; Lijffijt et al., 2005; Willcutt et al., 2005;
Wright et al., 2014).
In contrast with the consistent behavioral effects, previous attempts
to uncover the underlying brain mechanism that contributes to im-
paired response inhibition in ADHD patients have produced mixed re-
sults. Findings from functional magnetic resonance imaging (fMRI)
studies of ADHD participants (predominantly children) using Go/No-go
and Stop-Signal tasks suggest disrupted activation of a right-lateralized
fronto-striatal network implicated in response inhibition (see meta-
analyses in Cortese et al., 2012; Hart, Radua, Nakao, Mataix-Cols, &
Rubia, 2013; McCarthy, Skokauskas, & Frodl, 2014). However, in stu-
dies of adults with ADHD, results are much more inconsistent, and the
nature of neural disruption is unclear. As summarized by Congdon and
colleagues (Congdon et al., 2014), some studies report hypoactivation
in ADHD relative to neurotypicals (Cubillo et al., 2010; Montojo et al.,
2015; Mulligan et al., 2011; Sebastian et al., 2012), while other report
hyperactivation in ADHD (Dillo et al., 2010; Karch et al., 2010), or no
difference between patients and neurotypicals (Carmona et al., 2012;
Congdon et al., 2014). The problem is exacerbated by the tendency of
studies to report an extensive (and sometimes varied) network of re-
gions associated with inhibition, including inferior frontal cortex, the
insula, pre-supplementary motor area, medial-superior frontal gyrus,
cingulate cortex, the striatum and thalamus. It is therefore possible that
a coherent picture will emerge if a more specific set of brain regions can
be identified in respect to response inhibition.
In a recent study with neurotypical adults (Kolodny et al., 2017), we
utilized a unique experimental design of a Go/No-go task to increase
the specificity of inhibition-related activation. We manipulated the
ratio of Go and No-go stimuli, to create two variants of the task: rare-
No-go and prevalent-No-go (Fig. 1). While inhibition is required in all
No-go trials, a rare-No-go version (only 25% of trials are No-go) yields a
tendency to respond in every trial and hence a strong demand for in-
hibition is posed when a No-go stimulus appears, whereas a prevalent-
No-go version (75% of all trials are No-go) requires very little inhibition
effort. Thus, contrasting No-go trials from these different contexts
pinpoints inhibition-related brain activation. This design is different
from common Go/No-go and Stop-signal task designs that compare No-
go/Stop trials with Go trials, which therefore capture various differ-
ences between the trial types in addition to response inhibition – visual
properties, stimulus processing, motor planning and execution. Con-
versely, directly contrasting between No-go trials (rare vs. prevalent),
enables isolating inhibition-related activation while eliminating con-
taminating motor and visual factors. In our previous study including a
sample of neurotypical adults, this approach has been successful in
identifying specific inhibition-related activation in the intraparietal
sulcus (IPS) and in the left temporo-parietal junction (TPJ)
(Kolodny et al., 2017). Crucially, activity in these regions did not show
any differences between rare- and prevalent-Go trials, indicating that
their activation is not attributable to general processes of saliency de-
tection, attentional capture or expectancy, but is specifically related to
inhibition associated with the No-go trials.
The specificity achieved by such a task design in identifying re-
sponse inhibition processes in the brain is particularly relevant in the
context of ADHD, which has been also associated with a variety of other
(non response-inhibition) impairments, including sustained attention
(Hervey et al., 2004; Tsal et al., 2005), response selection
(Mullane et al., 2009; Segal et al., 2015), and temporal processing
(Dankner et al., 2017; Sonuga-Barke et al., 2010). These, among others,
may play a role in Go/No-go tasks, and are likely to alter the processing
and performance of both trial types (Go and No-go). Thus, when in-
vestigating response inhibition in ADHD, isolating inhibition-related
activation from other cognitive processes occurring throughout the
task, may prove critical.
In the current study, we examine inhibition-related brain activation
among adults with ADHD, as measured in a Go/No-go task by con-
trasting rare-No-go trials against prevalent-No-go trials, using a whole-
brain approach as well as ROI analyses in the IPS and TPJ. Furthermore,
we investigate whether the extent of inhibition-related activation is
related to the severity of ADHD symptoms. Such examination of in-
dividual differences in symptoms and in brain function has the benefit
of accommodating the considerable heterogeneity in ADHD
(Kofler et al., 2016; Nigg et al., 2005), and also provides evidence for
the potential clinical significance of abnormal inhibition-related brain
activation. Finally, we assess whether altered engagement of the par-
ietal cortex in inhibition is accompanied by altered fronto-parietal
connectivity using generalized context-dependent psychophysical in-
teractions (gPPI). Such an analysis may point to possible mechanisms
underlying an impaired IPS modulation in response inhibition in ADHD.
Fig. 1. Experimental design. Illustration
of the Go/No-go task, in which partici-
pants were shown a series of stimuli.
Participants were instructed to respond
quickly when a Go stimulus - a red square
- was presented in the center of a screen,
and to withhold response to all other sti-
muli. Trials occurred in a randomized
order within two types of runs: A) Rare-
No-go (25% No-go stimuli and 75% Go
stimuli) and B) Prevalent-No-go (75% No-
go stimuli and 25% Go stimuli). See
Methods Section 2.3 and Supplementary
Materials Section S for a full description of
the task.
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2. Methods and Materials
2.1. Participants
Forty-eight adults with ADHD participated in the study. 11 were
excluded due to various reasons, described in detail in the
Supplementary Materials Section 1 (e.g., abnormal neurological find-
ings, scanner artifacts, excessive motion). Thus, the final sample in-
cluded 37 participants, 15 men and 22 women, aged between 19 and 34
(mean age = 26.6, SD = 4.0). Participants were recruited through
advertisement within university and college campuses. All had a pre-
vious diagnosis of ADHD by a qualified clinician, and each participant
also completed a full psychiatric evaluation conducted by ST – a cer-
tified psychiatrist, which included psychiatric history and mental status
examination according to DSM-5 (APA, 2013) criteria. Participants
were excluded if they had neurological or psychiatric disorders other
than ADHD, including major depression, anxiety, OCD, or psychosis. All
participants met criteria for current diagnosis of ADHD and were not
using any psychotropic medications other than psychostimulants cus-
tomary to treat ADHD, and those receiving psychostimulants (11 par-
ticipants on a regular basis, 20 participants irregularly taking the
medicine) had at least 24-hours washout period before each testing
session. All had normal or corrected-to-normal vision (glasses were
replaced in the scanner with MRI-compatible goggles). Participants had
no contraindication to MRI scanning. The study conformed to the De-
claration of Helsinki and was approved by the ethics committees of
Sheeba medical center and of Tel-Aviv University in Israel. All parti-
cipants provided written informed consent after receiving a complete
description of the study.
2.2. Symptom severity
ADHD current symptom severity was scored using the Hebrew
version of the Adult ADHD Self-Report Scale (ASRS) (Kessler et al.,
2005; Zohar and Konfortes, 2010). The ASRS is comprised of 18 items
corresponding to the DSM diagnostic criteria. For each item, partici-
pants indicate how well the symptom describes them currently, on a
Likert scale (1=not at all, 5=to a large extent). The total score (overall
sum) of the ASRS gives an estimate of a participants’ current symptom
severity. The possible range of scores is from 18 to 90.
2.3. Go/No-go task
The Go/No-go task (Kolodny et al., 2017) consisted of a stream of
colored shapes, appearing one by one in the center of the screen. Each
shape appeared for 100 msec, with varying inter stimulus intervals
(Fig. 1). Participants were instructed to respond quickly when a Go
stimulus - a red square - was presented, and to withhold response to all
other stimuli. We are mostly interested in No-go trials, where partici-
pants must withhold their response. The task included two variants:
rare-No-go and prevalent-No-go. In the rare-No-go condition, 75% of
trials were Go trials and only 25% were No-go trials. In this case,
participants are required to respond in the majority of trials, and thus it
is difficult to withhold a response in the presence of rare No-go trials. In
the prevalent-No-go condition the ratio is inverted – 25% of trials are
Go trials and 75% are No-go trials. In this condition, there is no bias to
respond; hence the need for inhibition is greatly reduced. A complete
description of the task can be found in the Supplementary Materials
Section 2.
2.4. Experimental procedure
In order to get familiar with the task prior to the fMRI session,
participants attended the lab on a separate day and performed the Go/
No-go task in a regular lab setting. During the fMRI scan, participants
performed 4 blocks of the task: two of rare-No-go and two of prevalent-
No-go, interspersed by an anatomical T1-weighted scan. The order of
block types (rare- and prevalent-No-go) was counterbalanced across
participants. The stimuli were projected onto a screen and viewed by a
mirror mounted on the head coil. Responses were collected via an MRI-
compatible response box. Additional scans were acquired after com-
pletion of the experimental functional runs, and are not further de-
scribed in the current paper. The total period of time in the scanner was
approximately 60 minutes.
2.5. Behavioral data analysis
Paired t-tests were computed to compare performance in the rare-
No-go and prevalent-No-go conditions, in measures of mean reaction
time (RT), standard deviation of RT, omission and commission errors.
False Discovery Rate (FDR) was applied to correct for multiple com-
parisons. Effect sizes were estimated by Cohen's d for paired t-tests,
adjusted to correct for dependence among means (Morris and
DeShon, 2002).
2.6. fMRI analysis
fMRI data processing was carried out using FSL (FMRIB's Software
Library, www.fmrib.ox.ac.uk/fsl), version 5.0 (Jenkinson et al., 2012).
fMRI acquisition parameters and preprocessing steps are described in
detail in the Supplementary Materials Sections 3 and 4. Time-series
statistical analysis was carried out using FILM with local autocorrela-
tion correction (Worsley, 2001). Standard GLM fitting was conducted
for all subjects. The following events were modeled using a boxcar re-
gressor convolved with a canonical double gamma hemodynamic re-
sponse function: correct Go, correct No-go, omissions, and commission
errors. Null events were not modeled and therefore constitute an im-
plicit baseline. Events were modeled at the time of stimulus onset with
duration of 0.1 s. The six motion parameters and temporal derivatives
of all regressors were included as covariates of no interest to improve
statistical sensitivity. Volumes with framewise displacement (FD)> 0.9
were flagged and regressed out (“motion scrubbing”, Siegel et al., 2014;
see more details in the Supplementary Materials Section 5). Results from
a contrast of correct No-go trials (i.e. successful inhibitions) versus
baseline were fed into the second level analysis. The second level
analysis, combining runs within subject, was carried out using a fixed
effects model, by forcing the random effects variance to zero in FLAME
(FMRIB's Local Analysis of Mixed Effects) (Beckmann et al., 2003;
Woolrich, 2008; Woolrich et al., 2004). In order to isolate inhibition-
specific activation, a rare-No-go minus prevalent-No-go contrast was
computed for each subject. As described above, response inhibition is
highly challenging in the rare-No-go, but substantially less so in the
prevalent-No-go. Hence the contrast between No-go events in the two
conditions reflects the inhibitory process. To control for potential
confounds of saliency and expectancy in the abovementioned main
contrast, we also computed a rare-Go minus prevalent-Go contrast.
Group analysis was carried out using FLAME (FMRIB's Local
Analysis of Mixed Effects) stage 1 (Beckmann et al., 2003;
Woolrich, 2008; Woolrich et al., 2004). Z (Gaussianised T/F) statistic
images were thresholded using clusters determined by Z>2.3 and a
(corrected) cluster significance threshold of P=0.05 (Worsley, 2001),
corrected for multiple comparisons using Gaussian random field theory.
Activation clusters are reported in MNI coordinates, using Cluster
command in FSL. For visualization of results, statistical maps were
projected onto an average cortical surface with the use of multifiducial
mapping using CARET software (Van Essen, 2005) (http://brainvis.
wustl.edu/wiki/index.php/Caret:Download).
ROI analysis was conducted using masks of inhibition-related acti-
vation in neurotypical adults (masks are available online linked to
(Kolodny et al., 2017)). Percent signal change for each condition (rare-
No-go and prevalent-No-go) was computed in reference to an implicit
baseline and averaged across voxels within each cluster. Comparison of
T. Kolodny, et al. NeuroImage: Clinical 25 (2020) 102119
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the resulting values between conditions was conducted using paired t-
tests, and further complemented with Bayesian statistics to quantify the
support for the null hypothesis (see details in the Supplementary Ma-
terials Section 6).
In order to test the effect of symptom severity, a whole-brain re-
gression analysis was conducted at the group level, including demeaned
symptom severity scores as a covariate of interest. This allowed for
investigation of the relationship between inhibition-related activation,
as reflected in the difference between rare-No-go and prevalent-No-go
activation, and current symptom severity.
In order to visualize the latter, we extracted percent signal change
values for each condition (rare-No-go and prevalent-No-go). Percent
signal change was computed in reference to an implicit baseline in
clusters from group level analyses, and in intersection masks of current
group level analysis with ROI masks of parietal inhibition-related ac-
tivation in neurotypicals. Percent signal change is plotted against
symptom severity scores for visualization only, with no inferential
statistics, to avoid circular analysis and inflated correlation values
(Poldrack, 2007; Vul et al., 2009).
Three separate Follow-up analyses investigated effects of age, sex
and usage of psychostimulant medication. We compared inhibition-re-
lated activation between male and female participants; and between
participants who are treated regularly with psychostimulants vs. par-
ticipants using the medication sporadically (only 6 participants were
not using any psychostimulants, and these were excluded from this
analysis). Finally, we investigated the effect of age on inhibition-related
activation by including age as a covariate in the model.
2.7. Functional connectivity analysis: psychophysical interactions
Three generalized psychophysical interaction analyses (gPPI;
McLaren et al., 2012), were conducted to examine differential task-
based functional connectivity between seed regions derived from the
main analysis and other regions of the brain. The three selected seed
regions were located in the IPS (two clusters in the left IPS and one
cluster in the right IPS), defined from the intersection of the whole-
brain analysis result of symptom severity effects with the pre-defined
ROIs described above (depicted in Fig. 2B). For each seed region, the
seed mask was projected back to the native space of each participant,
and an averaged timeseries was extracted from the preprocessed fMRI
data. A standard GLM was ran for each run as described for the main
analysis, with the addition of gPPI interaction terms, created by mul-
tiplying the task regressors (Go and No-go events) with the seed ROI
timecourse, and creating a contrast of rare-No-go trials with prevalent-
No-go trials. In the group level analysis, demeaned ASRS scores were
entered as a covariate of interest, to allow investigation of how func-
tional connectivity patterns of the IPS are modulated by the task de-
mands as well as by individual differences in ADHD symptom severity.
3. Results
3.1. Behavioral results
Behavioral data were examined using paired sampled t-tests com-
paring the rare-No-Go condition to the prevalent-No-Go condition, in
order to assure the experimental manipulation. As expected, and as was
previously demonstrated with neurotypicals, RTs for Go trials were
significantly faster in the rare-No-go condition (M = 524 msec,
SD = 77) than in the prevalent-No-go condition (M = 586 msec,
SD = 79; t(36) = 13.0, p< .001, Cohen's d = 2.13), reflecting the
tendency to respond quickly that was created in the rare-No-go condi-
tion. Critically, commission errors occurred more frequently in the rare-
No-go condition (M = 7.6%, SD = 5.7) than in the prevalent-No-go
condition (M = 1.0%, SD = 1.2; t(36)=7.8, p< .001, Cohen's
d = 2.04). This demonstrates that the inhibition was indeed more de-
manding in the rare-No-go condition. Standard deviation of RT and rate
of omission errors did not differ between conditions (SDRT: M = 82.3
(SD = 34.2) vs. M = 81.9 (SD = 34.3) msec; omissions: M = 3.3%
(SD = 4.4) vs M = 4.3% (SD = 6.4), in the rare-No-go and the pre-
valent-No-go, respectively; t's < 2, n.s.), indicating similar levels of
sustained attention (Johnson et al., 2007; Shalev et al., 2011).
3.2. fMRI results
3.2.1. Inhibition-related activation
In order to isolate brain activation which is uniquely associated with
inhibition we used the contrast of No-go trials from the two different
occurrence rates: the activity in prevalent-No-go trials was subtracted
from the activity in rare-No-go trials. This contrast yielded no clusters
of activation, i.e. neural activity across the brain in response to No-go
stimuli was comparable regardless of the inhibitory demand.
To further examine this we employed regions of interest (ROIs)
approach, specifically looking into activation in the right and left IPS
and in the left TPJ, previously reported to be modulated by inhibitory
demand in this task (Kolodny et al., 2017). Paired t-tests comparing
percent signal change calculated within those ROIs, for rare-No-go and
for prevalent-No-go, revealed no significant differences in the extent of
activation between conditions, in any of the ROIs. Furthermore, Baye-
sian analysis provided conclusive evidence in favor of the null hy-
pothesis, i.e., no difference between conditions (Table 1). This em-
phasizes the null results of the whole-brain analysis, showing that for
adults with ADHD there is no difference between activation in rare-No-
go trials and activation in prevalent-No-go trials.
To examine the possibility that the data is noisy, hence rendering
any effect difficult to detect, we re-analyzed the data in the traditional
approach, contrasting No-go trials with Go-trials in the rare-No-go
condition. The activation map revealed occipital and parietal regions,
in line with the broad literature on Go/No-go tasks (Criaud and
Boulinguez, 2012; Swick et al., 2011) and matching closely with the
pattern of activation reported in neurotypicals using the same task
design (Kolodny et al., 2017). Frontal regions showed only modest re-
sponses, which is also in line with existing ADHD literature (e.g.
Congdon et al., 2014; Morein-Zamir et al., 2014; see detailed results in
the Supplementary Materials Section 7). These findings rule out the
possibility that the absence of specific inhibition-related activation is
the result of noisy data. Furthermore, we performed another control
analysis contrasting rare-Go trials with prevalent-Go trials. This ana-
lysis yielded large distributed activation throughout the brain (see de-
tailed results in the Supplementary Materials Section 8), including in
parietal cortex, demonstrating sensitivity to stimulus frequency. This
indicates that the absence of response in the main contrast of rare vs.
prevalent-No-go trials is specific to No-go stimuli, hence does not reflect
overall insensitivity to statistical regularities, and is presumably re-
flecting insensitivity to the associated inhibitory demand.
3.2.2. Effect of symptom severity
In order to examine the relationship between inhibition-related
activation and severity of ADHD symptoms, we added individuals’
ASRS questionnaire scores as a covariate to the GLM, testing for in-
teraction with the difference in activation between rare-No-go and
prevalent-No-go, which quantifies inhibition-related neural activity.
Interestingly, symptom severity was negatively correlated with such
difference in activation in multiple fronto-parietal regions (Fig. 2A and
Table 2). Importantly, these include left and right IPS, identified in
neurotypicals as involved in response inhibition. This means that par-
ticipants with ADHD experiencing relatively mild symptom severity
T. Kolodny, et al. NeuroImage: Clinical 25 (2020) 102119
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demonstrate a pattern of parietal inhibition-related activation that is
similar to that found in neurotypicals: higher activation in the IPS to-
wards rare-No-go stimuli than to prevalent-No-go stimuli, i.e., higher
activation when inhibition is difficult and demanding. On the other
hand, participants who report more severe behavioral manifestation of
ADHD show no difference in parietal activation between conditions
with different inhibitory demand, or even show a reverse pattern of
activation, where IPS is less activated when the demand for inhibition is
high. For visualization of this relation between brain activation and
behavioral symptoms, we show % signal change differences as a func-
tion of symptom severity, in regions of overlap between the current
results and the pre-defined ROIs in the IPS (Fig. 2B and C). Additional
Fig. 2. (A) Regions where inhibition-related activation is negatively correlated with ADHD symptom severity. See Table 2 for detailed cluster information. The
statistical map is corrected for whole-brain multiple comparisons and projected onto an average cortical surface using CARET (R = Right). The color bar represents
the z-score. (B) Regions of overlap between pre-defined regions of interest and Fig. 2A; i.e. regions identified in neurotypicals as inhibition-related that also
demonstrate correlation with symptom severity in adults with ADHD. (C) Scatter plots visualizing the correlation in these regions among ADHD participants:
inhibition-related activation as a function of ADHD symptom severity. Inhibition-related activation quantified as difference in % signal change between rare- and
prevalent-No-go, averaged across voxels in the clusters presented in B.
Table 1
Lack of parietal modulation in response inhibition among ADHD participants.
Brain region % signal change Rare-No-go Mean (SD) % signal change Prevalent-No-go Mean (SD) Paired-t statistic df = 37 BFnull
Right IPS 0.09 (0.20) 0.04 (0.14) 1.24 n.s. 2.83
Posterior Left IPS 0.07 (0.27) 0.11 (0.19) -0.74 n.s. 4.44
Left TPJ and anterior IPS 0.07 (0.16) 0.06 (0.13) 0.22 n.s. 5.59
Percent signal change for each condition was computed in reference to an implicit baseline and averaged across voxels within each ROI. BFnull = Bayes Factor in
favor of the null hypothesis, i.e. no difference between conditions. IPS = intraparietal sulcus; TPJ = temporoparietal junction.
T. Kolodny, et al. NeuroImage: Clinical 25 (2020) 102119
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scatter plots for all clusters of activation, as well as for the left TPJ ROI,
are included in the Supplementary Materials section 91.
Admittedly, the contrast of rare-No-go with prevalent-No-go over-
comes many shortcomings common in the response inhibition literature
as discussed earlier, but still contains some possible confounds that are
inherent to the design. Specifically, rare-No-go trials are more un-
expected than prevalent-No-go trials, and might be eliciting neural re-
sponses that are related to expectancy or saliency detection. To dis-
tinguish such effects from inhibition-related activations, we conducted
an analogous analysis based on Go trials, i.e. examining the interaction
of ASRS questionnaire scores with the difference in activation between
rare-Go and prevalent-Go. The analysis revealed clusters in bilateral
superior frontal gyrus and left inferior frontal gyrus (see detailed results
in the Supplementary Materials Section 8) where difference in activa-
tion between rare-Go and prevalent-Go were negatively associated with
ASRS scores. However, no such activation was seen in the parietal
cortex nor in any other regions identified in the No-go trials analysis.
These results confirm that the activation observed in the IPS is indeed
inhibition-related and not associated with general frequency effects.
3.2.3. Functional connectivity: generalized context-dependent
psychophysiological interactions
To further explore the possible underlying mechanisms of response-
inhibition we used the right and left IPS activation clusters depicted in
Fig. 2B, i.e. the intersection of the current whole-brain results with the
pre-defined ROIs, as seed-regions for whole-brain gPPI analyses. We
were particularly interested in the relationship between the IPS and
frontal regions previously suggested to be central to inhibition, in-
cluding the inferior frontal gyrus and the pre-supplementary motor area
(Aron et al., 2014, 2004; Chambers et al., 2009; Meffert et al., 2016;
Sharp et al., 2010), hypothesizing that top-down control from frontal
regions may be driving the IPS response to increased inhibitory de-
mand. A whole-brain exploratory analysis with the anterior left IPS
seed, including the ASRS symptom scores as a group-level covariate,
yielded a cluster of activation in the right inferior frontal gyrus (rIFG),
and a cluster in the right primary somatosensory cortex (postcentral
gyrus; Fig. 3, Table 3). When relaxing the statistical threshold, the same
cluster in the rIFG emerged also when using the other two seed regions:
the right IPS and the posterior left IPS. This finding indicates that the
modulation of connectivity between the IPS and the rIFG by the in-
hibitory demand correlates with the extent of ADHD severity: fronto-
parietal connectivity is elevated when response inhibition is challen-
ging (larger for rare-No-go trials than prevalent-No-go trials), but less
so for participants reporting high occurrence of ADHD symptoms.
3.2.4. Effect of sex, medication status and age
Follow-up analyses compared inhibition-related activation in male
vs. female participants, participants medicated regularly vs. those using
psychostimulants sporadically, and investigated the effect of age on
inhibition-related activation. None of these analyses yielded significant
results.
4. Discussion
In the present study we aimed to characterize abnormal patterns of
brain activation underlying impaired response inhibition in adult par-
ticipants with ADHD. The novelty of the current study, compared to
previous similar attempts, is in applying a unique task design that en-
ables isolation of inhibition-related activation. Contrasting rare-No-go
trials with prevalent-No-go trials avoided contamination of the results
by visual and motor components that are present in the Go trials.
Behaviorally, it was established that adults with ADHD had more dif-
ficulty inhibiting responses in the rare-No-go condition than in the
prevalent-No-go condition (with more commission errors expressing
inhibition failures), confirming a substantial increase in inhibitory de-
mand in this condition. While we have not compared performance
between ADHD and controls directly in this study, the rate of com-
mission errors of participants in the rare-No-go condition was 7.6% -
Table 2
Brain region Hemisphere N voxels Max Z-
stat
x y z
[rare-No-go minus prevalent-No-go] activation, negatively correlated with symptom severity
Precuneus, superior
parietal cortex, IPS
L 16,318 4.2 -9 -68 58
Superior frontal gyrus L 8313 3.6 -26 0 72
IPS R 5473 4.0 35 -41 51
Occipito-temporal lobe L 3086 3.6 -52 -60 6
Lateral prefrontal cortex L 3052 3.7 -35 45 15
Middle frontal gyrus R 2223 3.6 38 54 31
N Voxels: number of activated voxels per cluster; Max Z-stat: maximum z-sta-
tistic for each cluster; x, y, and z are MNI coordinates for peak of each cluster.
R = right; L = left. IPS = intraparietal sulcus.
Fig. 3. gPPI results for a seed region in the left anterior IPS (seed region shown
in Fig. 2B). Regions in the right IFG and in the right parietal cortex where the
modulation of correlation with the IPS seed time course by the inhibitory de-
mand negatively correlated with symptom severity of ADHD.
Table 3
Brain region Hemisphere N voxels Max Z-
stat
x y z
[rare-No-go minus prevalent-No-go] interaction with left IPS seed region in gPPI analysis,
negatively correlated with symptom severity




R 1794 3.32 28 -34 70
N Voxels: number of activated voxels per cluster; Max Z-stat: maximum z-sta-
tistic for each cluster; x, y, and z are MNI coordinates for peak of each cluster.
R = right; L = left. IFG = inferior frontal gyrus.
1 Note that the scatter plots are for visualization only, while statistical in-
ference is relying on the whole-brain analysis. While the reader might be in-
clined to look for correlation values accompanying this type of scatterplots,
computing any inferential correlational statistics in this case is misleading,
since the selection of regions was based on the same data rendering the analyses
non-independent. As demonstrated and discussed at length by Vul and collea-
gues, reporting correlation values in this situation of a non-independent ana-
lysis results in biased and inflated numbers (Poldrack and Mumford, 2009;
Poldrack, 2007; Vul et al., 2009).
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higher than that reported for neurotypical adults in the same task (4%,
Kolodny et al., 2017), which fits with previous reports on deficits in
inhibition of a prepotent response in participants with ADHD
(Nigg, 2000; Willcutt et al., 2005; Wright et al., 2014). Interestingly,
although the behavioral effect of No-go trial prevalence was substantial,
imaging results indicated no change in parietal responses between rare-
and prevalent-No-go conditions. This is in contrast with the pattern of
inhibition-related activation in parietal regions that was recently re-
ported in neurotypicals (Kolodny et al., 2017).
Importantly, the lack of parietal cortex recruitment is specifically
tied to the inhibitory demand: contrasting Go trials from different
prevalence yielded extensive brain-wide activations, including in the
parietal cortex, but not in the regions of interest in the IPS, demon-
strating intact sensitivity to stimulus frequencies. This analysis is also
an indication that the lack of IPS recruitment is not a result of increased
noise or variability in the ADHD cohort, which would undermine this
control analysis.
While we found no differentiated parietal engagement for response
inhibition on the group level, using an individual differences approach
it was revealed that inhibition-related activation in the parietal cortex
(including bilateral IPS) was, in fact, modulated by ADHD symptom
severity. Participants who reported moderate ADHD symptoms did
show the expected inhibition-related activation (similar to neurotypi-
cals) but this was eliminated in participants who evaluated themselves
as experiencing relatively high severity of symptoms. The link between
ADHD symptom severity and brain dynamics was further corroborated
using a gPPI analysis assessing functional connectivity between the IPS
and other brain regions in the context of response inhibition. We found
that the similarity of activation time courses between IPS and rIFG,
hypothesized to reflect functional connectivity between the two re-
gions, depended on the inhibitory demand and increased with inhibi-
tion difficulty, but crucially this effect was compromised with elevated
symptom severity of ADHD.
Indeed, the modulation of IPS-IFG functional connectivity by the
inhibitory demand fits with theories that highlight the role of the IFG in
response inhibition: the IFG is activated in various tasks requiring in-
hibition (Cai and Leung, 2011; Chikazoe et al., 2009; Garavan, 2002;
Rubia et al., 2003) and patients with damage to this brain region pre-
sent behavioral inhibitory failures (Aron et al., 2003; Rieger et al.,
2003). These findings gave rise to the long-standing view of the IFG as a
critical locus of response inhibition (Aron et al., 2014, 2004). In recent
years the specificity of the IFG to inhibitory function has been ques-
tioned (Chatham et al., 2012; Hampshire et al., 2010; Sharp et al.,
2010; Swick and Chatham, 2014), and it has been suggested that the
involvement of the IFG in response inhibition tasks results from its role
in domain-general fronto-parietal networks that support broader cog-
nitive control functions such as context monitoring (Banich and
Depue, 2015; Chatham et al., 2012; Criaud et al., 2017; Hampshire and
Sharp, 2015). In light of this view, and given our findings here and in
Kolodny et al. (2017), we suggest that while the IFG is not specifically
engaged in inhibition per se, its function in top-down control is es-
sential in modulating the parietal cortex according to the inhibitory
demand to achieve efficient response inhibition. Interestingly, a recent
exploratory analysis of parcellation-based functional connectivity of the
IFG during a stop-signal task identified the IPS as essential for response
inhibition, supporting our current framework (Osada et al., 2019).
The failure to modulate parietal activation in individuals who report
more severe ADHD symptoms may be a consequence of altered re-
sponses in the frontal regions, reflecting malfunctioning of cognitive
control in general. This is supported by behavioral findings indicating a
general deficit in context monitoring, including abnormally effortful
task switching deficits (Cepeda et al., 2000; King et al., 2007) and lack
of sensitivity to temporal regularities (Dankner et al., 2017), and by
neuroimaging evidence for hypoactivation of frontal regions, which is
well documented in ADHD in a variety of tasks (Cubillo et al., 2012;
Dickstein et al., 2006). Alternatively, lack of parietal modulation in
individuals who reported severe ADHD symptoms can stem from ab-
normal connectivity in fronto-parietal pathways. In this case the iden-
tification of the context and the stimuli properties (e.g. novelty, sal-
iency, prevalence) might be intact, but the ability to act upon this
information is limited by altered top-down connectivity to other brain
regions. This possibility is supported by reports of disrupted functional
connectivity in the fronto-parietal cognitive control network in ADHD
(Konrad and Eickhoff, 2010; Sripada et al., 2014), as well as in other
neural networks including the default-mode network, the ventral at-
tention network, and motor, saliency, and reward-based networks
(Castellanos and Aoki, 2016; O'Halloran et al., 2018). However, hypo-
activation and hypo-connectivity are bound together, and our current
data cannot tease these possibilities apart.
The current results also demonstrate how individual differences
analysis can unravel effects that may be concealed when using only
group-averaged statistics. This is especially important in research of
ADHD, which is a highly heterogeneous disorder, in its symptomatic
manifestation as well as in neuropsychological profiles and in psycho-
pathological pathways (Castellanos et al., 2006; Nigg et al., 2005;
Sonuga-Barke et al., 2010; Wåhlstedt et al., 2009). Moreover, while
current diagnosis is based on a categorical model of ADHD, recent
studies support the conceptualization of ADHD as a dimensional phe-
nomenon, that represents a continuum of attentional dysfunction from
normal functioning to extreme deficit (Coghill and Sonuga-Barke, 2012;
Frazier et al., 2007; Salum et al., 2014). The current results highlight
the merit of adopting a dimensional experimental design over the tra-
ditional comparison of patients with neurotypicals. While group com-
parison is unquestionably valuable, it suffers at the same time from
fundamental pitfalls when clinical groups are involved, primarily its
vulnerability to general group differences in variability and in noise
(e.g., motion artifacts, structural abnormalities, etc.; Nakao et al., 2011;
Satterthwaite et al., 2012). An ideal approach would thus be adopting a
fully dimensional design, with a large number of participants that re-
presents the complete range of attentional functioning. In the current
study, however, to balance sample size and statistical power with the
dimensional approach, and to align with current clinical standards of
ADHD definition, we chose to focus on the extremity of the attention
spectrum, including only participants with established and rigorous
ADHD diagnosis, and analyzing individual differences within this
clinical group. The convergence of the whole brain analysis in the
clinical group to the same regions of interest in the parietal cortex that
were pre-defined from neurotypicals’ activation maps provides strong
evidence for the contribution of the IPS to response inhibition. Inclusion
of participants from across the entire range of attention functioning in
future large-scale studies would allow further and wider examination of
this hypothesis.
A small number of previous studies focusing on inhibition also used
a similar dimensional approach, conducting a whole-brain regression
analysis between ADHD symptoms and brain function, but resulted in
inconsistent findings (Congdon et al., 2014; Cubillo et al., 2010;
Schneider et al., 2010). Those studies reported both negative and po-
sitive correlations of inhibition-related activation with symptom scores,
across a variety of brain regions. However, these studies were based on
the classic contrast of No-go or Stop trials versus Go trials. This contrast
might include activation that is unrelated to inhibition per se, but is a
consequence of motor, visual and/or perceptual processes that distin-
guish No-go from Go events. As such, it might also depend heavily on
the specific stimuli used in a certain study, and on factors other than
response inhibition that may be associated with the syndrome, all of
which may contribute to the inconsistencies among studies. Conse-
quently, the current results cannot be directly compared to these pre-
vious reports, due to the fundamental difference in the contrasts of
interest.
One factor that has been previously suggested to impact inhibition-
related activation in adults with ADHD is medication status. Current
psychostimulants treatment as well as the history of medication usage
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has been associated with the neural substrates of inhibition
(Congdon et al., 2014). While studies in children and youth with ADHD
show that acute administration of psychostimulants is linked with in-
creased stopping-related activation and even normalization of the
signal to the level of neurotypicals, there is no conclusive evidence
regarding long-term effects (Rubia et al., 2014; Schweren et al., 2013),
and there is only one report of such effects in adults (Bush et al., 2008;
Rubia et al., 2014). In the current study all of the participants had a
history of psychostimulants usage, and most of them were currently
treated. Thus, we could not directly address the effect of long-term
medication. However, when comparing participants reporting regular
usage of psychostimulants with participants reporting occasional usage
of psychostimulants, no differences were found in inhibition-related
activation. Future research is needed to inspect whether medication-
naïve participants show similar effects to those reported in the current
study.
To conclude, our findings whereby IPS engagement in response in-
hibition scales with symptom severity, point to this signal's potential
usefulness as a neuromarker of ADHD in adults and as a target for in-
tervention. The fact that fronto-parietal connectivity was similarly
sensitive to individual differences in symptom severity highlight the
two possible sources of this pattern of results – frontal hypoactivation
(possibly associated with reduced context sensitivity) or fronto-parietal
disconnection (possibly leading to impaired ability to act upon the
changing context). Both frontal activation and brain-wide connectivity
patterns can be effected by pharmacological intervention (Rubia et al.,
2009; Schmidt et al., 2017; Sweitzer et al., 2017), and as recently
shown, also by neurofeedback training (Alegria et al., 2017;
Rubia et al., 2018). Thus, future research can test whether normal-
ization of IFG responses would extend to normalization in IPS-IFG
connectivity and/or can lead to enhanced IPS modulation during re-
sponse inhibition, and whether such neural effects would be associated
with changes in symptom severity and other aspects of everyday
functioning. Targeting individual differences in such intervention stu-
dies can increase the impact and therapeutic value of such programs.
The current approach and findings could also be relevant to other
disorders associated with response inhibition abnormalities, such as psy-
chosis, schizophrenia, anxiety and obsessive-compulsive disorders, where a
similar framework can be used to examine the underlying neural me-
chanisms of impaired response inhibition on a group and individual levels.
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